title: Methotrexate-associated lymphoplasmacytic lymphoma complicated with type 2 cryoglobulinemia.
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasaki, Ten-noji, Osaka, 543-8555, Japan. matsui-y@osaka-med.jrc.or.jp.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Matsui
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasaki, Ten-noji, Osaka, 543-8555, Japan.
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Miura
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasaki, Ten-noji, Osaka, 543-8555, Japan.
authors.forename: Noriko
authors.initials: N
authors.lastname: Sugino
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasaki, Ten-noji, Osaka, 543-8555, Japan.
authors.forename: Hitomi
authors.initials: H
authors.lastname: Kaneko
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasaki, Ten-noji, Osaka, 543-8555, Japan.
authors.forename: Mitsumasa
authors.initials: M
authors.lastname: Watanabe
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasaki, Ten-noji, Osaka, 543-8555, Japan.
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Tsudo
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D003449:Cryoglobulinemia / Q000150:complications*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000139:chemically induced* / Q000150:complications; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate